Vivos (RDGL) Cash from Investing Activities (2010 - 2017)

Vivos' (RDGL) quarterly Cash from Investing Activities came in at $2800.0 in Q1 2017, up 280100.0% quarter-over-quarter from -$1.0 in Q4 2013.

Analysis

Vivos (RDGL) Cash from Investing Activities (2010 - 2017) Analysis & Trends

Vivos has disclosed Cash from Investing Activities across 5 years of filings, most recently posting $2800.0 for Q1 2017.

In Q1 2017, Cash from Investing Activities changed N/A year-over-year to $2800.0; the TTM figure through Dec 2017 stood at $2800.0 (changed N/A YoY), while the FY2025 annual figure was -$103185.0, changed N/A from the prior year.
Cash from Investing Activities came in at $2800.0 for Q1 2017 at Vivos, up from -$1.0 in the prior quarter.
In the past five years, Cash from Investing Activities ranged from a high of $16789.0 in Q2 2013 to a low of -$24504.0 in Q1 2013.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cash from Investing Activities (Qtr)
1	Abbott Laboratories	183.04 Bn	177.44 Bn	7.27 Bn	-673.00 Mn
2	Intuitive Surgical	125.02 Bn	119.81 Bn	1.96 Bn	-26.60 Mn
3	Medtronic	117.84 Bn	109.02 Bn	6.34 Bn	-1.62 Bn
4	Stryker	105.50 Bn	102.02 Bn	4.50 Bn	-639.00 Mn
5	Boston Scientific	66.27 Bn	65.73 Bn	3.85 Bn	-1.96 Bn
6	Edwards Lifesciences	49.60 Bn	45.35 Bn	1.35 Bn	-193.20 Mn
7	Alcon	33.70 Bn	32.24 Bn	1.68 Bn	-222.00 Mn
8	Dexcom	32.06 Bn	30.11 Bn	830.00 Mn	329.80 Mn
9	Steris	21.02 Bn	20.54 Bn	684.20 Mn	-108.50 Mn
10	Vivos	23.21 Mn	23.21 Mn	-	-

Historic Data

Download Data